Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alzchem Group AGCHIX:ACTD 50 3-Year EBITDA Growth Rate is 19.80% as of Mar. 2026, which is 101% above its 10-year median of 9.85. GuruFocus rates CHIX:ACTD with a GF Score™ of 50/100. The stock has 4 warning signs investors should review. Among 1,409 Chemicals companies, Alzchem Group AG ranks better than 80.77% on this metric.
During the past 12 months, Alzchem Group AG's average EBITDA Per Share Growth Rate was 13.10% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 19.80% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 17.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Alzchem Group AG was 19.80% per year. The lowest was -72.70% per year. And the median was 9.85% per year.
Alzchem Group AG (CHIX:ACTd) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Alzchem Group AG 3-Year EBITDA Growth Rate Related Terms
CHIX:ACTD vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Alzchem Group AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alzchem Group AG 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Alzchem Group AG's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Alzchem Group AG's 3-Year EBITDA Growth Rate falls into.
Alzchem Group AG 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 19.80% mean?
Alzchem Group AG (CHIX:ACTD) has a 3-Year EBITDA Growth Rate of 19.80% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Alzchem Group AG and its competitors. This is 101% above median its historical median of 9.85. According to the industry distribution chart, Alzchem Group AG ranks #271 out of 1409 companies in the Chemicals industry, placing it in the top 19.2%.
Is Alzchem Group AG's 3-Year EBITDA Growth Rate too high?
Alzchem Group AG's current 3-Year EBITDA Growth Rate of 19.80% is 101% above median its 10-year median of 9.85. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.90. Alzchem Group AG's value of 19.80% is 2100% above this industry median. Based on the distribution chart, Alzchem Group AG ranks #271 out of 1409 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Alzchem Group AG has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, Alzchem Group AG ranks #271 out of 1409 companies for 3-Year EBITDA Growth Rate. This places Alzchem Group AG in the top 19% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.90. Alzchem Group AG's value of 19.80% is 2100% above this benchmark. While the company's 10-year median is 9.85 vs. the industry median of 0.90, Alzchem Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.90, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alzchem Group AG's current 3-Year EBITDA Growth Rate of 19.80% is 2100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Alzchem Group AG and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alzchem Group AG's current 3-Year EBITDA Growth Rate is 19.80%, which is 101% above median its own 10-year median of 9.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (CHIX:ACTD) has a current 3-Year EBITDA Growth Rate of 19.80%. The current 3-Year EBITDA Growth Rate is 19.80%, which is 101% above median its 10-year median of 9.85 and 2100% above the Chemicals industry median of 0.90. Alzchem Group AG's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Alzchem Group AG (CHIX:ACTD), the current 3-Year EBITDA Growth Rate is 19.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
50GF Score
Get the complete analysis for CHIX:ACTD
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ACTD has been successfully added to your 
